Larimar Therapeutics, Inc. — Director's Dealing 2016

Jan 27, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ZAFGEN, INC. (ZFGN)
CIK: 0001374690
Period of Report: 2016-01-25

Reporting Person: LAMATTINA JOHN L (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-01-25	Stock Option (Right to Buy)	$7.91	A	9150	Acquired	2026-01-25	Common Stock (9150)	Direct

Footnotes

F1: The stock option was issued in lieu of cash fees under the Non-Employee Director Compensation Policy pursuant to a Non-Qualified Stock Option Agreement and shall vest over a period of one year starting January 1, 2016 on a quarterly basis in arrears.